Search Results
10
Everything
Hepatitis B Therapeutics Competitive Landscape Report: 184 Molecules in the Pipeline - 1 Asset in Pre-registration Stage, 1 Asset in Phase III Development, and 36 Assets in Phase II Development
February 28, 2025 06:34 ET
|
Research and Markets
Dublin, Feb. 28, 2025 (GLOBE NEWSWIRE) -- The "Hepatitis B Therapeutics: Competitive Landscape" report has been added to ResearchAndMarkets.com's offering.This reports provides a data-driven...
2025 Hydroxychloroquine Drugs Market Research Report: Industry Poised for Steady Growth Through 2030, Increasing from $1.174 Billion in 2025 to $1.336 Billion
February 14, 2025 08:39 ET
|
Research and Markets
Dublin, Feb. 14, 2025 (GLOBE NEWSWIRE) -- The "Hydroxychloroquine Drugs Market - Forecasts from 2025 to 2030" report has been added to ResearchAndMarkets.com's offering. In a comprehensive analysis...
Norfloxacin (CAS 70458-96-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Capacity, Production, Consumption, Manufacturing, End-users, Trade, Prices
February 14, 2025 06:40 ET
|
Research and Markets
Dublin, Feb. 14, 2025 (GLOBE NEWSWIRE) -- The "Norfloxacin (CAS 70458-96-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ...
India Cephalexin Market Report 2025: Industry Projected to Reach USD 85.08 Million by 2030 with a Significant CAGR of 4.88%
January 31, 2025 08:38 ET
|
Research and Markets
Dublin, Jan. 31, 2025 (GLOBE NEWSWIRE) -- The "India Cephalexin Market, By Region, Competition, Forecast & Opportunities, 2020-2030F" report has been added to ResearchAndMarkets.com's offering....
8MM Respiratory Syncytial Virus Prophylaxis Market Drug Analysis Report: Prophylactic Options to Continue to Diversify Due to Strength of Late-Stage Pipeline - Forecast to 2030
December 20, 2024 10:05 ET
|
Research and Markets
Dublin, Dec. 20, 2024 (GLOBE NEWSWIRE) -- The "Respiratory Syncytial Virus Prophylaxis: Eight-Market Drug Forecast and Market Analysis - Update" report has been added to ResearchAndMarkets.com's...
Vancomycin Markets - Global Strategic Business Report Q4, 2024
December 18, 2024 04:05 ET
|
Research and Markets
Dublin, Dec. 18, 2024 (GLOBE NEWSWIRE) -- The "Vancomycin - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Vancomycin was...
Chronic Pseudomonas Aeruginosa Pulmonary Infections Pipeline Insight 2024 - Pipeline Drug Profiles, Including Clinical and Non-clinical Stage Products
December 06, 2024 04:13 ET
|
Research and Markets
Dublin, Dec. 06, 2024 (GLOBE NEWSWIRE) -- The "Chronic Pseudomonas Aeruginosa Pulmonary Infections - Pipeline Insight, 2024" has been added to ResearchAndMarkets.com's offering.This report provides...
Sepsis Epidemiology Forecast Report to 2033
November 04, 2024 06:46 ET
|
Research and Markets
Dublin, Nov. 04, 2024 (GLOBE NEWSWIRE) -- The "Sepsis: Epidemiology Forecast to 2033" report has been added to ResearchAndMarkets.com's offering.Sepsis and septic shock are life-threatening...
Antifungal Drugs Market Projected to Reach USD 19.16 Billion by 2030 Amid Rising Incidence of Fungal Infections - Global Research 2024
November 01, 2024 10:18 ET
|
Research and Markets
Dublin, Nov. 01, 2024 (GLOBE NEWSWIRE) -- The "Anti Fungal Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.In...
Antiviral Drugs Market Poised for Growth with Impressive CAGR until 2030, Driven by Rising Disease Prevalence and Treatment Advances
November 01, 2024 10:02 ET
|
Research and Markets
Dublin, Nov. 01, 2024 (GLOBE NEWSWIRE) -- The "Antiviral Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering. ...